Reduced expression of hCLCA1 predicts disease relapse and poor survival in patients with colorectal cancer,64 and is an independent risk factor of poor disease-free survival in patients with pancreatic ductal adenocarcinoma.66 The gene discussed is CLCA1; the disease is colorectal cancer.